Effects of MIF-1 and three related peptides on reserpine-induced hypothermia in mice
暂无分享,去创建一个
[1] A. Kastin,et al. Radioimmunoassayable N-Tyr-MIF-1-like activity in rat brain is increased by pinealectomy , 1981, Brain Research Bulletin.
[2] R. Olson,et al. Low doses of naloxone and MIF-1 peptides increases fluid consumption in rats , 1981, Pharmacology Biochemistry and Behavior.
[3] A. Kastin,et al. Naloxone-like actions of MIF-1 do not require the presence of the pituitary , 1980, Pharmacology Biochemistry and Behavior.
[4] A. Kastin,et al. Radioimmunoassay of MIF-1/Tyr-MIF-1-like material in rat pineal , 1980, Pharmacology Biochemistry and Behavior.
[5] A. Kastin,et al. Interaction of MIF-I or alpha-MSH with D-amphetamine or chlorpromazine on thermoregulation and motor activity of rats maintained at different ambient temperatures , 1980, Peptides.
[6] R. Olson,et al. MIF-I's differential actions as an opiate antagonist , 1979, Pharmacology Biochemistry and Behavior.
[7] Ehrensing Rh,et al. Dose-related biphasic effect of prolyl-leucyl-glycinamide (MIF-I) in depression. , 1978 .
[8] J. M. Ree,et al. Prolyl-leucyl-glycinamide (PLG) facilitates morphine dependence , 1976 .
[9] S. Castensson,et al. Studies on the inhibition of oxotremorine induced tremor by a melanocyte‐stimulating hormone release‐inhibiting factor, thyrotropin releasing hormone and related peptides , 1974, FEBS letters.
[10] A. Kastin,et al. Oxotremorine Antagonism by a Hypothalamic Hormone, Melanocyte-Stimulating Hormone Release-Inhibiting Factor (MIF) , 1972, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[11] A. Kastin,et al. DOPA potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF). , 1971, Life sciences. Pt. 1: Physiology and pharmacology.
[12] B. Askew. A SIMPLE SCREENING PROCEDURE FOR IMIPRAMINE-LIKE ANTIDEPRESSANT AGENTS. , 1963, Life sciences.
[13] J. C. Burke,et al. Bioassay of Rauwolfia roots and alkaloids. , 1957, The Journal of pharmacology and experimental therapeutics.
[14] A. Kastin,et al. Antagonistic actions of MIF-I on the hypothermia and hypomotility induced by beta-endorphin or morphine. , 1980, The International journal of neuroscience.
[15] L. B. Flexner,et al. Prolyl-leucyl-glycinamide, cyclo(leucylglycine), and derivatives block development of physical dependence on morphine in mice. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[16] K. Voith. Synthetic MIF analogues. Part II: Dopa potentiation and fluphenazine antagonism. , 1977, Arzneimittel-Forschung.
[17] A. Kastin,et al. Melanocyte-stimulating hormone-release inhibiting hormone as a antidepressant. A pilot study. , 1974, Archives of general psychiatry.
[18] A. Kastin,et al. Deserpidine antagonism by a tripeptide, L-prolyl-L-leucyglycinamide. , 1973, Neuroendocrinology.